| Literature DB >> 34959838 |
Daniel Wilson1,2, Matthew Driller3, Paul Winwood2, Ben Johnston4, Nicholas Gill2,5.
Abstract
The aim of this study was to perform a 12-month follow-up of health parameters after a 17-week lifestyle intervention in overweight airline pilots. A parallel-group (intervention and control) study was conducted amongst 72 overweight airline pilots (body mass index > 25) over a 12-month period following the emergence of COVID-19. The intervention group (n = 35) received a personalized dietary, sleep, and physical activity program over a 17-week period. The control group (n = 37) received no intervention. Measurements for subjective health (physical activity, sleep quality and quantity, fruit and vegetable intake, and self-rated health) via an electronic survey, and objective measures of body mass and blood pressure were taken at baseline and at 12 months. Significant interactions for group × time from baseline to 12-months were found for all outcome measures (p < 0.001). Body mass and mean arterial pressure significantly decreased in the intervention group when compared to the control group (p < 0.001). Outcome measures for subjective health (physical activity, sleep quality and quantity, fruit and vegetable intake, and self-rated health) significantly increased in the intervention group when compared to the control group (p < 0.001). Results provide preliminary evidence that a brief three-component healthy sleep, diet and physical activity intervention can elicit and sustain long-term improvements in body mass and blood pressure management, health behaviors, and perceived subjective health in pilots and may support quality of life during an unprecedented global pandemic.Entities:
Keywords: healthy eating; lifestyle medicine; moderate-to-vigorous physical activity; sleep; weight loss
Mesh:
Year: 2021 PMID: 34959838 PMCID: PMC8707615 DOI: 10.3390/nu13124288
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Flow diagram of participant recruitment and data collection.
Baseline characteristics of participants.
| Parameters | All Participants ( | Intervention ( | Control ( |
|---|---|---|---|
| Sex (f/m) | 11/61 | 7/28 | 4/33 |
| Age (year) | 45.8 ± 11.1 | 42.8 ± 10.4 | 48.7 ± 11.2 * |
| Height (cm) | 178.6 ± 7.2 | 178.5 ± 8.1 | 178.6 ± 6.3 |
| Body mass (kg) | 90.4 ± 13.9 | 91.7 ± 13.5 | 89.2 ± 14.5 |
| BMI (kg∙m2) | 28.3 ± 3.3 | 28.7 ± 3.3 | 27.9 ± 2.8 |
| Systolic BP (mmHg) | 134.4 ± 11.8 | 138.4 ± 10.6 | 130.6 ± 11.7 |
| Diastolic BP (mmHg) | 84.8 ± 8.3 | 86.7 ± 8.1 | 83.1 ± 8.2 |
| MAP (mmHg) | 101.3 ± 8.5 | 103.9 ± 8.0 | 98.9 ± 8.5 * |
| Pulse (bpm) | 68.7 ± 9.5 | 69.2 ± 7.8 | 68.1 ± 10.9 |
| Hours slept (h/day) | 7.3 ± 0.9 | 7.0 ± 0.8 | 7.6 ± 0.8 * |
| IPAQ-walk (min) | 102.4 ± 58.5 | 69.0 ± 37.9 | 134.0 ± 57.2 * |
| IPAQ-MVPA (min) | 144.5 ± 89.0 | 125.9 ± 79.7 | 162.1 ± 94.7 |
| F&V Intake (serve/day) | 3.5 ± 1.4 | 2.8 ± 1.3 | 4.1 ± 1.1 * |
| PCS-12 (score) | 46.7 ± 6.6 | 42.1 ± 4.1 | 51.1 ± 5.5 * |
| MCS-12 (score) | 49.1 ± 7.5 | 45.3 ± 8.2 | 52.7 ± 4.5 * |
| Short Haul ( | 28 (39%) | 20 (57%) | 8 (22%) * |
| Long Haul ( | 35 (49%) | 13 (37%) | 22 (59%) |
| Mixed Fleet ( | 9 (12%) | 2 (6%) | 7 (19%) |
| Flights during lockdown ( | 8.0 ± 7.4 | 7.9 ± 7.7 | 8.1 ± 7.2 |
| Flight hours after lockdown (h) | 152.1 ± 71.9 | 153.9 ± 63.8 | 150.5 ± 79.7 |
Mean ± SD reported for all participants, intervention and control. Abbreviations: SD = standard deviation. BMI—body mass index. BP = blood pressure. MAP = mean arterial pressure. IPAQ = International Physical Activity Questionnaire. MVPA = moderate-to-vigorous physical activity. F&V = fruit and vegetable intake. PCS-12 = physical component summary score. MCS-12 = mental component summary score. * indicates statistical significance between groups (p < 0.05). Flight hours after lockdown = flight hours during the 6-months prior to 12-months follow-up testing.
Changes in objective and subjective health metrics from baseline and follow-up at 12-months.
| Time (Months) | Intervention | Control | ANOVA (Time × Group Interaction) | Between Group ES | |||||
|---|---|---|---|---|---|---|---|---|---|
| ( | ( | ||||||||
| M | SD | Follow-Up Change (95% CI) | M | SD | Follow-Up Change (95% CI) |
|
| ||
| Body mass (kg) | 0 | 91.7 | 13.5 | 89.2 | 14.5 | 0.2, | |||
| 12 | 86.8 | 11.3 | −4.9 (−3.5–−6.3) | 90.5 | 14.5 | 1.3 (0.6–1.9) | <0.001 | −0.3, | |
| BMI (kg/m2) | 0 | 28.7 | 3.3 | 27.9 | 2.8 | 0.2, | |||
| 12 | 27.1 | 2.7 | −1.6 (−1.1–−2.0) | 28.3 | 3.7 | 0.4 (0.2–0.6) | <0.001 | −0.4, | |
| Systolic BP (mmHg) | 0 | 138.4 | 10.6 | 130.6 | 11.7 | 0.7 *, | |||
| 12 | 128.1 | 10.3 | −10.3 (−7.2–−13.5) | 134.4 | 9.9 | 3.8 (0.0–7.6) | <0.001 | −0.6 *, | |
| Diastolic BP (mmHg) | 0 | 86.7 | 8.1 | 83.1 | 8.2 | 0.4, | |||
| 12 | 78.9 | 8.0 | −7.8 (−5.0–−10.6) | 83.2 | 7.0 | 0.1 (−2.6–2.8) | <0.001 | −0.6 *, | |
| MAP (mmHg) | 0 | 103.9 | 8.0 | 98.9 | 8.5 | 0.6 *, | |||
| 12 | 95.3 | 7.6 | −8.6 (−6.0–−11.3) | 100.2 | 7.2 | 1.3 (−1.2–4.0) | <0.001 | −0.7 *, | |
| Pulse (bpm) | 0 | 69.2 | 7.8 | 68.1 | 10.9 | 0.1, | |||
| 12 | 63.4 | 8.5 | −5.8 (−3.8–−8.2) | 69.2 | 12.2 | 1.1 (−0.7–5.6) | <0.001 | −0.7 *, | |
| Hours slept (h/day) | 0 | 7.0 | 0.8 | 7.6 | 0.8 | −0.7 *, | |||
| 12 | 7.7 | 0.7 | 0.7 (0.4–1.1) | 7.5 | 0.7 | −0.1 (0.0–−0.3) | <0.001 | 0.4, | |
| PSQI Global (score) | 0 | 6.4 | 2.8 | 4.5 | 2.6 | 0.7 *, | |||
| 12 | 4.1 | 1.5 | −2.3 (−1.7–−3.2) | 5.0 | 2.7 | 0.5 (0.2–0.7) | <0.001 | −0.5 *, | |
| IPAQ-walk (min) | 0 | 69.0 | 37.9 | 134.0 | 57.2 | −1.3 **, | |||
| 12 | 102.3 | 69.2 | 33.3 (22.1–49.6) | 122.6 | 77.6 | −11.4 (−16.2–9.4) | <0.001 | −0.6 *, | |
| IPAQ-MVPA (min) | 0 | 125.9 | 79.7 | 162.1 | 94.7 | −0.4, | |||
| 12 | 227.0 | 83.0 | 101.1 (62.2–126.0) | 159.0 | 99.8 | −3.1 (−16.9–11.1) | <0.001 | 0.8 *, | |
| F&V Intake (serve/day) | 0 | 2.8 | 1.3 | 4.1 | 1.1 | −1.1 **, | |||
| 12 | 5.5 | 1.7 | 2.7 (2.0–3.2) | 3.9 | 1.3 | −0.2 (−0.5–0.1) | <0.001 | 1.1 **, | |
| PCS-12 (score) | 0 | 42.1 | 4.1 | 51.1 | 5.5 | −1.8 **, | |||
| 12 | 51.7 | 4.0 | 9.6 (7.1–10.8) | 50.7 | 4.9 | −0.4 (−1.3–0.2) | <0.001 | 0.1, | |
| MCS-12 (score) | 0 | 45.3 | 8.2 | 52.7 | 4.5 | −1.1 **, | |||
| 12 | 51.1 | 4.9 | 5.8 (3.6–8.0) | 51.8 | 4.7 | −0.9 (−0.1–−1.7) | <0.001 | 0.2, | |
Mean ± SD reported for all participants, intervention, and control. Abbreviations: SD = standard deviation. BMI = body mass index. BP = blood pressure. MAP = mean arterial pressure. PSQI = Pittsburgh Sleep Quality Index. IPAQ = International Physical Activity Questionnaire. F&V = fruit and vegetable intake. PCS-12 = physical component summary score. MCS-12 = mental component summary score. * indicates statistical significance between groups (p < 0.05). ** indicates statistical significance between groups (p < 0.001).
Figure 2Mean values on objective and subjective health outcomes measured across time (Baseline and 12-months), showing 95% confidence intervals. (a), Bodyweight; (b), Mean Arterial Presurre; (c), Pittsburgh Sleep Quality Indx; (d), Fruit and Vegetable Intake, (e) Weekly Waliking Minuters; (f), Weekly MVPA Minutes; (g) PCS-12; (h), MCS-12. MVPA = moderate-to-vigorous physical activity. PCS-12 = physical component summary score. MCS-12 = mental component summary score. * indicates a significant difference compared to Baseline.
Additional analysis: Changes in objective and subjective health metrics from post intervention at 4-months to follow-up at 12-months in the intervention group.
| Time (Months) | Intervention ( | Effect Size | |||
|---|---|---|---|---|---|
| M | SD | Post-Follow-Up Change (95% CI) |
| ||
| Body mass (kg) | 4 | 87.7 | 12.8 | - | - |
| 12 | 86.8 | 11.3 | −0.97 (−1.81–0.1) | −0.47, | |
| BMI (kg/m2) | 4 | 27.5 | 3.1 | - | - |
| 12 | 27.1 | 2.7 | −0.32 (−0.58–0.07) | −0.44, | |
| Systolic BP (mmHg) | 4 | 130.9 | 11.1 | - | - |
| 12 | 128.1 | 10.3 | −2.89 (−6.09–0.32) | −0.31, | |
| Diastolic BP (mmHg) | 4 | 83.8 | 9.7 | - | - |
| 12 | 78.9 | 8.0 | −4.86 (−7.56–−2.15) | −0.62, | |
| MAP (mmHg) | 4 | 99.5 | 9.4 | - | - |
| 12 | 95.3 | 7.6 | −4.11 (−6.77–−1.46) | −0.53, | |
| Pulse (bpm) | 4 | 62.6 | 7.2 | - | - |
| 12 | 63.4 | 8.5 | 0.74 (−2.0–3.5) | 0.09, | |
| Hours slept (h/day) | 4 | 7.8 | 1.0 | - | - |
| 12 | 7.7 | 0.7 | −0.11 (−0.27–0.05) | −0.23, | |
| PSQI Global (score) | 4 | 4.1 | 1.8 | - | - |
| 12 | 4.1 | 1.5 | −0.09 (−0.31–0.14) | −0.13, | |
| IPAQ-walk (min) | 4 | 94.3 | 96.5 | - | - |
| 12 | 102.3 | 69.2 | 8.0 (−10.4–26.4) | 0.15, | |
| IPAQ-MVPA (min) | 4 | 207.6 | 79.0 | - | - |
| 12 | 227.0 | 82.6 | 19.7 (5.57–33.74) | 0.48, | |
| F&V Intake (serve/day) | 4 | 5.6 | 1.9 | - | - |
| 12 | 5.5 | 1.7 | −0.13 (−0.49–0.23) | 0.12, | |
| PCS-12 (score) | 4 | 52.3 | 4.5 | - | - |
| 12 | 51.7 | 4.0 | −0.54 (−1.38–0.29) | −0.22, | |
| MCS-12 (score) | 4 | 54.5 | 5.7 | - | - |
| 12 | 51.1 | 4.9 | −0.52 (−1.41–0.36) | −0.20, | |
Mean ± SD reported for the intervention group. Abbreviations: SD = standard deviation. BMI = body mass index. BP = blood pressure. MAP = mean arterial pressure. PSQI = Pittsburgh Sleep Quality Index. IPAQ = International Physical Activity Questionnaire. F&V = fruit and vegetable intake. PCS-12 = physical component summary score. MCS-12 = mental component summary score. * indicates statistical significance (p < 0.05). ** indicates statistical significance (p < 0.001).